{"id":8075,"date":"2024-05-14T12:15:00","date_gmt":"2024-05-14T12:15:00","guid":{"rendered":"https:\/\/www.acarix.com\/kommunike-fran-arsstamma-i-acarix-ab-2\/"},"modified":"2024-11-18T19:04:35","modified_gmt":"2024-11-18T19:04:35","slug":"kommunike-fran-arsstamma-i-acarix-ab-2","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/","title":{"rendered":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p class=\"mfn-wp-retain\"><strong>&Aring;rsst&auml;mman 2024 i Acarix AB (&#8220;Acarix&#8221; eller &#8220;Bolaget&#8221;) h&ouml;lls idag den 14 maj 2024 varvid aktie&auml;garna fattade f&ouml;ljande beslut.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p class=\"mfn-wp-retain\"><strong>Fastst&auml;llande av resultat- och balansr&auml;kningen<\/strong><\/p>\n<p class=\"mfn-wp-retain\">&Aring;rsst&auml;mman beslutade att fastst&auml;lla resultatr&auml;kningen och balansr&auml;kningen i Acarix samt koncernresultatr&auml;kningen och koncernbalansr&auml;kningen.<\/p>\n<p class=\"mfn-wp-retain\"><strong>Vinstdisposition<\/strong><\/p>\n<p class=\"mfn-wp-retain\">&Aring;rsst&auml;mman beslutade att ingen utdelning skulle utg&aring; till aktie&auml;garna samt att tidigare balanserade medel, inklusive &ouml;verkursfond samt &aring;rets resultat balanseras i ny r&auml;kning.<\/p>\n<p class=\"mfn-wp-retain\"><strong>Ansvarsfrihet<\/strong><\/p>\n<p class=\"mfn-wp-retain\">Styrelsens ledam&ouml;ter och den verkst&auml;llande direkt&ouml;ren beviljades ansvarsfrihet f&ouml;r verksamhets&aring;ret 2023.<\/p>\n<p class=\"mfn-wp-retain\"><strong>Val av styrelse och revisor samt arvodering<\/strong><\/p>\n<p class=\"mfn-wp-retain\">&Aring;rsst&auml;mman beslutade, i enlighet med valberedningens f&ouml;rslag, att styrelsen ska best&aring; av fyra ledam&ouml;ter. Det beslutades &auml;ven att Bolaget ska ha ett registrerat revisionsbolag som revisor.<\/p>\n<p class=\"mfn-wp-retain\">Det beslutades, i enlighet med valberedningens f&ouml;rslag, att arvodet till styrelsens ledam&ouml;ter ska uppg&aring; till totalt 1 400 000 kronor och utg&aring; till styrelsens och inr&auml;ttade utskottsledam&ouml;ter enligt f&ouml;ljande (1 200 000 kronor f&ouml;reg&aring;ende &aring;r):<\/p>\n<ul>\n<li>500 000 kronor (400 000 kronor) till styrelseordf&ouml;randen och 300 000 SEK (200 000 kronor) till &ouml;vriga ledam&ouml;ter, och<\/li>\n<li>0 kronor (0 kronor) till ordf&ouml;randen i revisions- respektive ers&auml;ttningsutskottet och &ouml;vriga ledam&ouml;ter av utskott.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\">Vidare beslutades att arvode till revisor ska utg&aring; enligt godk&auml;nd r&auml;kning.<\/p>\n<p class=\"mfn-wp-retain\">&Aring;rsst&auml;mman beslutade, i enlighet med valberedningens f&ouml;rslag, att omv&auml;lja de nuvarande styrelseledam&ouml;terna Marlou Janssen-Counotte och Philip Siberg samt att v&auml;lja Ken Nelson och Dr. Tony Das till nya styrelseledam&ouml;ter. Philip Siberg omvaldes till styrelseordf&ouml;rande.<\/p>\n<p class=\"mfn-wp-retain\">PricewaterhouseCoopers AB omvaldes till revisor f&ouml;r Bolaget. PricewaterhouseCoopers AB har anm&auml;lt auktoriserade revisorn Alexander St&aring;hl som ny huvudansvarig revisor.<\/p>\n<p class=\"mfn-wp-retain\"><strong>Bemyndigande f&ouml;r styrelsen att besluta om emissioner<\/strong><\/p>\n<p class=\"mfn-wp-retain\">&Aring;rsst&auml;mman beslutade, i enlighet med styrelsens f&ouml;rslag, att bemyndiga styrelsen att intill n&auml;sta &aring;rsst&auml;mma vid ett eller flera tillf&auml;llen besluta om emission av aktier, konvertibler och\/eller teckningsoptioner, med eller utan avvikelse fr&aring;n aktie&auml;gares f&ouml;retr&auml;desr&auml;tt, till ett antal motsvarande maximalt tjugo (20) procent av det totala antalet aktier i Bolaget vid tidpunkten f&ouml;r &aring;rsst&auml;mman, att betalas kontant, genom apport och\/eller genom kvittning.<\/p>\n<p class=\"mfn-wp-retain\">Att styrelsen ska kunna fatta beslut om emission utan f&ouml;retr&auml;desr&auml;tt f&ouml;r aktie&auml;garna enligt ovan &auml;r fr&auml;mst i syfte att kunna anskaffa nytt kapital f&ouml;r att &ouml;ka Bolagets flexibilitet eller i samband med f&ouml;rv&auml;rv.<\/p>\n<p class=\"mfn-wp-retain\">Utgivande av nya aktier, konvertibler eller teckningsoptioner med st&ouml;d av bemyndigandet ska genomf&ouml;ras p&aring; sedvanliga villkor under r&aring;dande marknadsf&ouml;rh&aring;llanden. Om styrelsen finner det l&auml;mpligt f&ouml;r att m&ouml;jligg&ouml;ra leverans av aktier i samband med en emission enligt ovan kan detta g&ouml;ras till ett teckningspris motsvarande aktiernas kvotv&auml;rde.<\/p>\n<p class=\"mfn-wp-retain\">F&ouml;r detaljerade villkor avseende besluten p&aring; st&auml;mman enligt ovan h&auml;nvisas till kallelsen samt de fullst&auml;ndiga f&ouml;rslagen som finns tillg&auml;ngligt p&aring; Bolagets hemsida, <a href=\"http:\/\/www.acarix.com.\" rel=\"noopener\" target=\"_blank\">www.acarix.com<\/a>.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-5f6793025012\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">F&ouml;r mer information, kontakta:<\/strong><br \/>Jennifer Anderson, Chef Marknad &amp; Kommunikation, tel +1 720 471 4625, email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ja928lyd5LVtH4Zqz3RIoAP_vZ4DwD4jGGSS8irkeyApUfYtjFhf7OEe4gNScgnB2UBNq2dY0DN26ofiUpN4WG_gdBET6JivdcXqFArn7NQ=\" rel=\"noopener\" target=\"_blank\">jennifer.anderson@acarix.com<\/a>&nbsp;<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-ddf9d1ef3849\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Om Acarix<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">Acarix &auml;r ett svenskt medicintekniskt f&ouml;retag som utvecklar l&ouml;sningar f&ouml;r att snabbt utesluta kransk&auml;rlssjukdom (CAD) vid patientn&auml;ra v&aring;rd. Det CE-godk&auml;nda och FDA DeNovo-godk&auml;nda Acarix CADScor-systemet &auml;r avsett f&ouml;r patienter som upplever br&ouml;stsm&auml;rta med misst&auml;nkt kransk&auml;rlssjukdom och &auml;r utformat f&ouml;r att bidra till att minska miljontals on&ouml;diga, invasiva och kostsamma diagnostiska procedurer. CADScor-systemet har anv&auml;nts p&aring; mer &auml;n 29 000 patienter. Acarix rekommenderar CADScor System som ett f&ouml;rsta linjens diagnostiskt hj&auml;lpmedel som anv&auml;nder mycket k&auml;nslig akustik och avancerad ber&auml;kningsbearbetning f&ouml;r att analysera kransk&auml;rlsblodfl&ouml;det f&ouml;r att utesluta betydande kransk&auml;rlssjukdom (CAD), med minst 96 % s&auml;kerhet vid v&aring;rdtillf&auml;llet. Acarix &auml;r noterat p&aring; Nasdaq First North Premier Growth Market i Stockholm (ticker: ACARIX). Carnegie Investment Bank AB (publ) &auml;r Certified Advisor till Acarix. F&ouml;r mer information, bes&ouml;k <a href=\"http:\/\/www.acarix.com\" rel=\"noopener\" target=\"_blank\">www.acarix.com<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/d4c225a1-17a9-443d-b4e0-05bb5d595eec\/kommunike-fran-arsstamma-i-acarix-ab.pdf\" rel=\"noopener\" target=\"_blank\">Kommunik&eacute; fr&aring;n &aring;rsst&auml;mma i Acarix AB<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-primary\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/d4c225a1-17a9-443d-b4e0-05bb5d595eec\/kommunike-fran-arsstamma-i-acarix-ab.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/d4c225a1-17a9-443d-b4e0-05bb5d595eec\/kommunike-fran-arsstamma-i-acarix-ab.pdf?type=jpg\"><\/span>Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>&Aring;rsst&auml;mman 2024 i Acarix AB (&#8220;Acarix&#8221; eller &#8220;Bolaget&#8221;) h&ouml;lls idag den 14 maj 2024 varvid aktie&auml;garna fattade f&ouml;ljande beslut. Fastst&auml;llande<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[177,178,140,154,139,148,180,142],"tags":[],"class_list":["post-8075","post","type-post","status-publish","format-standard","hentry","category-mfn-ci","category-mfn-ci-gm","category-mfn-type-ir","category-mfn-regulatory-listing","category-mfn","category-mfn-regulatory","category-mfn-ci-gm-info","category-mfn-lang-sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB - Acarix\" \/>\n<meta property=\"og:description\" content=\"&Aring;rsst&auml;mman 2024 i Acarix AB (&#8220;Acarix&#8221; eller &#8220;Bolaget&#8221;) h&ouml;lls idag den 14 maj 2024 varvid aktie&auml;garna fatt\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-14T12:15:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T19:04:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"acarix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"acarix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/\"},\"author\":{\"name\":\"acarix\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"headline\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB\",\"datePublished\":\"2024-05-14T12:15:00+00:00\",\"dateModified\":\"2024-11-18T19:04:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/\"},\"wordCount\":823,\"articleSection\":[\"Corporate Information\",\"General meeting\",\"IR\",\"Listing Regulation\",\"News\",\"Regulatory\",\"Report of the AGM\",\"Swedish\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/\",\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2024-05-14T12:15:00+00:00\",\"dateModified\":\"2024-11-18T19:04:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/kommunike-fran-arsstamma-i-acarix-ab-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\",\"name\":\"acarix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"caption\":\"acarix\"},\"sameAs\":[\"https:\\\/\\\/www.acarix.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB - Acarix","og_description":"&Aring;rsst&auml;mman 2024 i Acarix AB (&#8220;Acarix&#8221; eller &#8220;Bolaget&#8221;) h&ouml;lls idag den 14 maj 2024 varvid aktie&auml;garna fatt","og_url":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/","og_site_name":"Acarix","article_published_time":"2024-05-14T12:15:00+00:00","article_modified_time":"2024-11-18T19:04:35+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"author":"acarix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"acarix","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/"},"author":{"name":"acarix","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"headline":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB","datePublished":"2024-05-14T12:15:00+00:00","dateModified":"2024-11-18T19:04:35+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/"},"wordCount":823,"articleSection":["Corporate Information","General meeting","IR","Listing Regulation","News","Regulatory","Report of the AGM","Swedish"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/","url":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/","name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2024-05-14T12:15:00+00:00","dateModified":"2024-11-18T19:04:35+00:00","author":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-arsstamma-i-acarix-ab-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Acarix AB"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5","name":"acarix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","url":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","caption":"acarix"},"sameAs":["https:\/\/www.acarix.com"]}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=8075"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8075\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=8075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=8075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=8075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}